Literature DB >> 31437135

The dawn of immunotherapy for breast cancer.

Leisha A Emens1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31437135

Source DB:  PubMed          Journal:  Clin Adv Hematol Oncol        ISSN： 1543-0790


× No keyword cloud information.
  3 in total

Review 1.  Peripheral Blood Transcriptome in Breast Cancer Patients as a Source of Less Invasive Immune Biomarkers for Personalized Medicine, and Implications for Triple Negative Breast Cancer.

Authors:  Helena Čelešnik; Uroš Potočnik
Journal:  Cancers (Basel)       Date:  2022-01-25       Impact factor: 6.639

Review 2.  The history of small extracellular vesicles and their implication in cancer drug resistance.

Authors:  Stefano Palazzolo; Vincenzo Canzonieri; Flavio Rizzolio
Journal:  Front Oncol       Date:  2022-08-24       Impact factor: 5.738

Review 3.  Exosomes and breast cancer drug resistance.

Authors:  Xingli Dong; Xupeng Bai; Jie Ni; Hao Zhang; Wei Duan; Peter Graham; Yong Li
Journal:  Cell Death Dis       Date:  2020-11-17       Impact factor: 8.469
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.